OLN-93 oligodendrocytes synthesize all-trans-retinoic acid in vitro.
After traumatic injury to the central nervous system (CNS), various cytokines orchestrate the physiological responses of injured neurons and glial cells. The control of these intercellular signals is of major interest from a medical point of view. Since the transcriptional activator retinoic acid (RA) is known to regulate gene expression of cytokines in various cell culture systems we investigated the role of RA signaling in glial cells. The transcriptional activity of RA-induced genes is largely determined by the distribution of RA, which in turn depends on the local oxidation of retinaldehyde (RAL). This is synthesized from retinol or internalized as a component of vitamin A. Using high-pressure liquid chromatography and an RA-sensitive reporter cell line, we showed that OLN-93 cells, which serve as a model system for CNS oligodendrocytes, convert all-trans-RAL to the biologically active form all-trans-RA, but neither oxidize 9-cis-RAL nor isomerize RA enzymatically. The oligodendrocyte cell line expresses a cytosolic aldehyde dehydrogenase with an apparent molecular weight of 54-57 kDa and pI of 5.3-5.7. As indicated by a zymography bioassay, this enzyme is responsible for RA synthesis. The reaction requires NAD+ as cosubstrate and can be inhibited by disulfiram and citral. No other RA-producing enzyme activities were detected. These findings are in accordance with a putative role for retinoid signaling in neuroglial interactions in the CNS.
Mey
J
J
Institut für Biologie II, Zoologie/Tierphysiologie, RWTH Aachen, Germany. mey@bio2.rwth-aachen.de
Hammelmann
S
S
D000444:Aldehyde Dehydrogenase / Q000378:metabolism; D000077556:Alitretinoin; D000818:Animals; D001681:Biological Assay; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid; D009836:Oligodendroglia / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D018168:Receptors, Retinoic Acid / Q000187:drug effects / Q000502:physiology; D018243:Teratocarcinoma; D014162:Transfection; D014212:Tretinoin / Q000378:metabolism* / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D018168:Receptors, Retinoic Acid; C082925:retinoic acid receptor beta; D000077556:Alitretinoin; D014212:Tretinoin; D000444:Aldehyde Dehydrogenase